Dental Care Clinics in Kihei, HI Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Kihei Dentists Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 300 Ohukai Rd Ste B301, Kihei, HI 96753 Phone: 808-538-6522 |
Margaret C. Garcia Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1300 N Holopono St # 209, Kihei, HI 96753 Phone: 808-875-1400 Fax: 808-875-0479 |
Special Care Dentistry, Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 56 Ehiku Loop Ste 2, Kihei, HI 96753 Phone: 808-633-6931 Fax: 888-222-3530 |
Hawaii Family Dental Centers-kihei Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 1847 S Kihei Rd, Suite 101, Kihei, HI 96753 Phone: 808-874-8401 Fax: 808-874-6921 |
Cally L. Adams, Dds, Llc Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1325 S Kihei Rd, Suite 108, Kihei, HI 96753 Phone: 808-875-4808 Fax: 808-875-4841 |
Maui Pediatric Dentistry Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1280 S Kihei Rd Apt 206, Kihei, HI 96753 Phone: 808-757-5259 |
News Archive
International task force aims to develop new approach to cancer prevention and treatment
Advancements in precision medicine have led to many new targeted cancer therapies for cancer patients. These treatments focus on using agents that target one or two genes that contribute to tumor development. The approach tends to be more effective against cancer cells and less toxic toward normal cells than standard chemotherapeutic regimens.
New analysis finds link between cloudy drinking water and gastrointestinal illness
Cloudy drinking water, even if it's within the limits allowed by some cities, was linked to increased cases of gastrointestinal illness, according to new Drexel University analysis.
FDA clears Nanosphere's RV+ test for detection of respiratory viruses
Nanosphere, a leader in the development and commercialization of advanced molecular diagnostics systems, announced today FDA 510(k) clearance for the Verigene Respiratory Virus Plus Nucleic Acid Test on the Verigene System.
Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility
Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
› Verified 3 days ago